Name

MMV

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for MMV

Name

Alternate Names

Ametycine
Mito-Medac
Mitocin
Mitocin-C
MitoExtra
Mitomycin-C
Mitomycin-X
Mutamycin
Mutamycine

Abbreviations

MITC
Mito
MITO-C
MMC
MTC

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

26980
026980

Primary Site

Breast
Cervical cancer
Gastric cancer
Head and Neck (in combination with radiation therapy)
Non-small cell lung cancer (NSCLC)
Pancreatic cancer
Superficial bladder cancer

Histology

None

Remarks

FDA approved for treatmen of many cancers.

Coding

This drug should be coded

Name

Alternate Names

Amethopterin
Antifolan
CL-14377
Folex
Methotrexate Sodium
Mexate
Mexate AQ
Rheumatrex
WR-19039

Abbreviations

MTX

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

740
000740

Primary Site

Acute lymphoblastic leukemia (ALL)
Bladder cancer
Breast
Gestational trophoblastic cancer
head & neck cancer
lymphoma
Meningeal leukemia
Non-Hodgkin lymphoma
Osteogenic sarcoma
Primary CNS lymphoma

Histology

None

Remarks

FDA approved uses on ALL, breast cancer, choriocarcinoma, head and neck cancer, lymphoma, and osteosarcoma.

Coding

This drug should be coded

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary